Table 2—

Absolute changes in fasting glucose, insulin, lipids, and HbA1c from baseline for the RT & WL and WL groups, and the net difference between groups

3-month change from baseline
6-month change from baseline
RT & WLWLNet difference (95% CI)RT & WLWLNet difference (95% CI)
Fasting plasma glucose (mmol/l)−0.5 ± 2.30.09 ± 2.5−0.6 (−2.4 to 1.3)−1.4 ± 2.7−0.6 ± 2.4−0.8 (−2.8 to 1.2)
Fasting serum insulin (pmol/l)7.1 ± 43.316.4 ± 60.3−9.3 (−48.8 to 30.2)10.5 ± 46.3−4.7 ± 27.215.2 (−14.7 to 45.1)
Insulin sensitivity (HOMA) (%)−1.3 ± 4.6−0.3 ± 6.1−1.0 (−5.2 to 3.1)0.03 ± 5.20.8 ± 6.5−0.8 (−5.2 to 3.7)
HbA1c (%)−0.6 ± 0.7*−0.07 ± 0.8−0.5 (−1.1 to −0.01)−1.2 ± 1.0*−0.4 ± 0.8−0.8 (−1.5 to −0.1)
Serum lipids (mmol/l)
 Total cholesterol−0.03 ± 0.6−0.2 ± 0.90.2 (−0.4 to 0.7)−0.09 ± 0.8−0.5 ± 0.80.4 (−0.3 to 1.1)
 HDL cholesterol0.02 ± 0.10.07 ± 0.2−0.05 (−0.1 to 0.05)0.06 ± 0.10.07 ± 0.2−0.01 (−0.1 to 0.1)
 LDL cholesterol0.03 ± 0.4−0.2 ± 0.90.2 (−0.3 to 0.7)−0.06 ± 0.7−0.5 ± 0.90.4 (−0.2 to 1.0)
 Triglycerides−0.2 ± 0.7−0.05 ± 0.9−0.2 (−0.8 to 0.4)−0.2 ± 0.7−0.08 ± 0.6−0.1 (−0.7 to 0.4)
  • Data are means ± SD or means (95% CI). Net difference refers to the within-group change from baseline in the RT & WL group minus the within-group change from baseline in the WL group.

  • *

    * P < 0.01 within-group difference from baseline;

  • P < 0.05 between-group difference from baseline.